Optimal design for population pk/pd models

[1] ALIEV, A.-FEDOROV, V.-LEONOV, S.-MCHUGH, B.: PkStaMp library for opti- mization of sampling schemes for PK/PD models, in: Proc. of the 6th St. Petersburg Workshop on Simulation, Vol. 1 (S. M. Ermakov et al., eds.), VVM com Ltd., St. Petersburg, Russia, 2009, pp. 368-374.Search in Google Scholar

[2] ALIEV, A.-FEDOROV, V.-LEONOV, S.-MCHUGH, B.-MAGEE, M.: PkStaMp library for constructing optimal population designs for PK/PD studies, Commun. Stat., Simulation Comput. 41 (2012), 717-729.Search in Google Scholar

[3] ATKINSON, A. C.-DONEV, A.: Optimum Experimental Design. Clarendon Press, Oxford, 1992.Search in Google Scholar

[4] ATWOOD, C. L.: Sequences converging to D-optimal designs of experiments, Ann. Stat. 1 (1973), 342-352.10.1214/aos/1176342371Search in Google Scholar

[5] BATES, D. M.-WATTS, D. G.: Nonlinear Regression Analysis and its Applications. Wiley, New York, 1988.10.1002/9780470316757Search in Google Scholar

[6] BAZZOLI, C.-RETOUT, S.-MENTR´ E, F.: Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model, Stat. Med. 28 (2009), 1940-1956.10.1002/sim.357319266541Search in Google Scholar

[7] DUFFULL, S. B.-WATERHOUSE, T. H.-ECCLESTON, J. A.: Some considerations on the design of population pharmacokinetic studies, J. Pharmacokin. Pharmacodyn. 32 (2005), 441-457.10.1007/s10928-005-0034-216284917Search in Google Scholar

[8] FEDOROV, V. V.: Theory of Optimal Experiment. Academic Press, New York, 1972.Search in Google Scholar

[9] FEDOROV, V. V.-GAGNON, R.-LEONOV, S.-WU, Y.: Optimal design of experi- ments in pharmaceutical applications, in: Pharmaceutical Statistics Using SAS. A Practical Guide (A. Dmitrienko et al., eds.), SAS Press, Cary, NC, 2007, 151-195.Search in Google Scholar

[10] FEDOROV, V. V.-HACKL, P.: Model-Oriented Design of Experiments. Springer, New York, 1997.10.1007/978-1-4612-0703-0Search in Google Scholar

[11] FEDOROV, V. V.-LEONOV, S.: Response driven designs in drug development, in: Applied Optimal Designs (W. K. Wong and M. P. F. Berger, eds.), Wiley, Chichester, 2005, pp. 103-136.10.1002/0470857005.ch5Search in Google Scholar

[12] GAGNON, R.-LEONOV, S.: Optimal population designs for PK models with serial sampling, J. Biopharm. Statist. 15 (2005), 143-163.10.1081/BIP-20004085315702610Search in Google Scholar

[13] GUEORGUIEVA, I.-OGUNGBENRO,K.-GRAHAM,G.-GLATT, S.-AARONS, L.: A program for individual and population optimal design for univariate and multivari- ate response pharmacokinetic-pharmacodynamic models, Comput. Methods Programs Biomed. 86 (2007), 51-61.10.1016/j.cmpb.2007.01.00417292995Search in Google Scholar

[14] MAGNUS, J. R.-NEUDECKER, H.: Matrix Differential Calculus with Applications in Statistics and Econometrics. Wiley, New York, 1988.10.2307/2531754Search in Google Scholar

[15] MENTR´ E, F.-NYBERG, J.-OGUNGBENRO, K.-LEONOV, S.-ALIEV, A.-DUFFULL, S.-BAZZOLI, C.-HOOKER, A.: Comparison of results of the different software for design evaluation in population pharmacokinetics and pharmacodynamics, in: Abstracts of the Annual Meeting of the Population Approach Group in Europe (PAGE), 2011, http://www.page-meeting.org/default.asp?abstract=2066.Search in Google Scholar

[16] MERL´ E, Y.-TODD, M.: Impact of pharmacokineticpharmacodynamic model lineariza- tion on the accuracy of population information matrix and optimal design, J. Pharmacokin. Pharmacodyn. 28 (2001), 363-388.10.1023/A:1011534830530Search in Google Scholar

[17] MIELKE, T.-SCHWABE, R.: Some considerations on the Fisher information in nonlin- ear mixed effects models, in: mODa 9-Advances in Model-Oriented Design and Analysis (A. Giovagnoli et al., eds.), Physica-Verlag/Springer, Berlin, 2010, pp. 129-136.10.1007/978-3-7908-2410-0_17Search in Google Scholar

[18] MONOLIX: http://www.lixoft.net/monolix/overview/, Lixoft, 2011.Search in Google Scholar

[19] NEUMANN, A. U.-LAM, N. P.-DAHARI, H.-GRETCH, D. R.-WILEY, T. E.- -LAYDEN, T. J.-PERELSON, A. S.: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-_ therapy, Science 282 (1998), 103-107.10.1126/science.282.5386.1039756471Search in Google Scholar

[20] NYBERG, J.-UECKERT, S.-STR¨OMBERG, E.-KARLSSON, M. O.-HOOKER, A. C.: PopED, version 2.12, 2011, http://poped.sourceforge.net. Search in Google Scholar

[21] P´AZMAN, A.: Nonlinear Statistical Models. Kluwer Academic Publshers, Dordrecht, 1993.Search in Google Scholar

[22] RATKOWSKY, D. A.: Nonlinear Regression Modeling. Marcel Dekker, New York, 1983.Search in Google Scholar

[23] RETOUT, S.-MENTR´ E, F.: Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics, J. Biopharm. Statist. 13 (2003), 209-227.10.1081/BIP-12001926712729390Search in Google Scholar

[24] WYNN, H. P.: The sequential generation of D-optimal experimental designs, Ann. Math. Statist. 41 (1970), 1655-1664.10.1214/aoms/1177696809Search in Google Scholar